Credit Suisse Group reaffirmed their outperform rating on shares of Quintiles Transitional Holdings Inc. (NYSE:Q) in a research note published on Monday. They currently have a $110.00 target price on the medical research company’s stock, up from their previous target price of $98.00.

A number of other research analysts also recently issued reports on the stock. Citigroup Inc. reiterated a neutral rating and issued a $96.00 price target (up previously from $87.00) on shares of Quintiles Transitional Holdings in a research note on Wednesday, June 28th. Robert W. Baird upgraded shares of Quintiles Transitional Holdings from an underperform rating to a neutral rating and lifted their price target for the stock from $76.00 to $93.00 in a research note on Friday, July 7th. Zacks Investment Research upgraded shares of Quintiles Transitional Holdings from a hold rating to a buy rating and set a $101.00 price target for the company in a research note on Thursday, July 27th. Barclays PLC reiterated an overweight rating and issued a $98.00 price target (up previously from $90.00) on shares of Quintiles Transitional Holdings in a research note on Monday, July 17th. Finally, Argus lifted their price target on shares of Quintiles Transitional Holdings from $98.00 to $104.00 and gave the stock a buy rating in a research note on Monday, September 18th. Eleven research analysts have rated the stock with a hold rating, nine have issued a buy rating and one has assigned a strong buy rating to the company’s stock. Quintiles Transitional Holdings presently has a consensus rating of Buy and a consensus target price of $94.38.

Quintiles Transitional Holdings (NYSE:Q) opened at 99.33 on Monday. The company’s 50 day moving average is $95.87 and its 200 day moving average is $89.00. Quintiles Transitional Holdings has a 1-year low of $70.10 and a 1-year high of $100.57. The company has a market cap of $21.51 billion, a price-to-earnings ratio of 287.91 and a beta of 0.62.

Quintiles Transitional Holdings (NYSE:Q) last issued its quarterly earnings results on Thursday, August 3rd. The medical research company reported $1.09 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.05 by $0.04. Quintiles Transitional Holdings had a net margin of 0.82% and a return on equity of 14.23%. The company had revenue of $1.97 billion during the quarter, compared to the consensus estimate of $1.96 billion. During the same quarter in the previous year, the firm earned $0.93 earnings per share. The firm’s quarterly revenue was up 68.7% on a year-over-year basis. Equities research analysts forecast that Quintiles Transitional Holdings will post $4.58 EPS for the current year.

TRADEMARK VIOLATION WARNING: This piece was originally reported by Daily Political and is owned by of Daily Political. If you are accessing this piece on another site, it was illegally stolen and republished in violation of US and international trademark and copyright laws. The original version of this piece can be read at https://www.dailypolitical.com/2017/10/17/quintiles-transitional-holdings-inc-q-given-outperform-rating-at-credit-suisse-group.html.

In other news, insider Ari Bousbib sold 46,080 shares of Quintiles Transitional Holdings stock in a transaction on Monday, October 2nd. The shares were sold at an average price of $94.91, for a total value of $4,373,452.80. Following the transaction, the insider now directly owns 1,036,839 shares of the company’s stock, valued at approximately $98,406,389.49. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Kevin C. Knightly sold 20,000 shares of Quintiles Transitional Holdings stock in a transaction on Wednesday, August 9th. The shares were sold at an average price of $90.28, for a total transaction of $1,805,600.00. Following the completion of the transaction, the insider now directly owns 46,826 shares in the company, valued at $4,227,451.28. The disclosure for this sale can be found here. Insiders sold a total of 14,198,382 shares of company stock worth $1,361,834,375 over the last ninety days. Corporate insiders own 6.40% of the company’s stock.

Several institutional investors have recently made changes to their positions in Q. Janus Henderson Group PLC increased its holdings in shares of Quintiles Transitional Holdings by 33,092.0% in the 2nd quarter. Janus Henderson Group PLC now owns 6,531,857 shares of the medical research company’s stock valued at $584,601,000 after acquiring an additional 6,512,178 shares during the period. Glenview Capital Management LLC increased its holdings in shares of Quintiles Transitional Holdings by 29.3% in the 2nd quarter. Glenview Capital Management LLC now owns 8,921,356 shares of the medical research company’s stock valued at $798,461,000 after acquiring an additional 2,023,719 shares during the period. Royal Bank of Canada increased its holdings in shares of Quintiles Transitional Holdings by 103.8% in the 2nd quarter. Royal Bank of Canada now owns 59,335 shares of the medical research company’s stock valued at $5,310,000 after acquiring an additional 1,601,888 shares during the period. Discovery Capital Management LLC CT acquired a new position in shares of Quintiles Transitional Holdings in the 2nd quarter valued at $95,228,000. Finally, Laurion Capital Management LP acquired a new position in shares of Quintiles Transitional Holdings in the 2nd quarter valued at $54,510,000. 93.22% of the stock is currently owned by institutional investors and hedge funds.

Quintiles Transitional Holdings Company Profile

Quintiles IMS Holdings, Inc, formerly Quintiles Transnational Holdings Inc, provides integrated information and technology-enabled healthcare services. The Company operates through segments, including Commercial Solutions; Research & Development Solutions, and Integrated Engagement Services. The Commercial Solutions segment offerings include national information offerings, sub-national information offerings, technology solutions, and workflow analytics and consulting services.

Analyst Recommendations for Quintiles Transitional Holdings (NYSE:Q)

Receive News & Ratings for Quintiles Transitional Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quintiles Transitional Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.